A Phase I, Open-Label Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500921-34-00

Acronym

ACH-CYT-05

Enrollment

Registered

2022-10-24

Start date

2022-12-13

Completion date

2023-09-06

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine addiction

None listed

Sex/Gender

All

Age

18 Years to No maximum

Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026